Significantly extends commercial reach of Growth Direct through expanded global sales channels; enables opportunities for ...

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission ...

Reports record fourth quarter 2024 total revenue of $8.2 million, representing 30% growth compared to fourth quarter 2023; recurring revenue ...

Shares in Rapid Micro Biosystems jumped Friday in premarket trading after it said it signed an agreement with Merck's life science business to distribute its microbiology testing platform. Shares ...

Sees 21-25 system replacements in FY25.Discover the Best Stocks and Maximize Your Portfolio: See what stocks are receiving Strong Buy ratings ...

Rapid Micro Biosystems, Inc.’s RPID share price has surged by 22.14%, which has investors questioning if this is right time ...

The life sciences technology company posted a loss of $0.22 per share for Q4, $0.01 worse than the analyst estimate of -$0.21. Revenue came in at $8.2 million, beating the consensus estimate of $7.8 ...

Rapid Micro Biosystems, Inc. (RPID) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.26 per share a year ago. These ...

Reports record fourth quarter 2024 total revenue of $8.2 million, representing 30% growth compared to fourth quarter 2023; recurring revenue increased by 27% compared to the fourth quarter of 2023.Ann ...

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the "Company" or "Rapid Micro"), an innovative life sciences technology company providing mission critical ...

Rapid Micro Biosystems (NASDAQ:RPID – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Friday, February 28th. Analysts expect Rapid Micro Biosystems to post ...

LEXINGTON, Mass., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company ...